Recent studies have clearly shown that CA, particularly transthyretin-related amyloidosis (ATTR), is a leading cause of heart failure (HF), affecting approximately 15% of subjects with HF with preserved ejection fraction (HFpEF) [1]. This evidence concerns the gene TTR and amyloidosis.